Cargando…

Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegeneration

Detalles Bibliográficos
Autores principales:	Simó, Rafael, Hernández, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664137/ https://www.ncbi.nlm.nih.gov/pubmed/37843198 http://dx.doi.org/10.4103/1673-5374.353492

Ejemplares similares

Effect of Topical Administration of Somatostatin on Retinal Inflammation and Neurodegeneration in an Experimental Model of Diabetes
por: Hernández, Cristina, et al.
Publicado: (2020)

Topical Administration of Bosentan Prevents Retinal Neurodegeneration in Experimental Diabetes
por: Bogdanov, Patricia, et al.
Publicado: (2018)

Topical Administration of Somatostatin Prevents Retinal Neurodegeneration in Experimental Diabetes
por: Hernández, Cristina, et al.
Publicado: (2013)

Mechanisms of retinal neuroprotection of calcium dobesilate: therapeutic implications
por: Simó-Servat, Olga, et al.
Publicado: (2017)

Effects of the Topical Administration of Semaglutide on Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes
por: Simó, Rafael, et al.
Publicado: (2021)

Neurodegeneration in branch retinal vein occlusion
por: Alshareef, Rayan A., et al.
Publicado: (2016)

Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model
por: Bogdanov, Patricia, et al.
Publicado: (2022)

Antioxidant Effects of DPP-4 Inhibitors in Early Stages of Experimental Diabetic Retinopathy
por: Ramos, Hugo, et al.
Publicado: (2022)

Effects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration
por: Bogdanov, Patricia, et al.
Publicado: (2018)

Topical Ocular Povidone-Iodine as an Adjunctive Preventative Practice in the Era of COVID-19
por: O’Brien, Terrence P., et al.
Publicado: (2021)

Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
por: Solerte, Sebastiano Bruno, et al.
Publicado: (2020)

Guardians of the eye: new tales about retinal microglia and other ocular macrophages
por: Rosmus, Dennis-Dominik, et al.
Publicado: (2021)

Strategies to treat neurodegeneration in neuronal ceroid lipofuscinosis: a view onto the retina
por: Bartsch, Udo
Publicado: (2022)

Neurotrophin receptors, gamma-secretase inhibitors, and neurodegeneration of basal forebrain cholinergic neurons
por: Vilar, Marçal
Publicado: (2021)

DPP-IV Inhibitor–Associated Angioedema in Patient With Known History of ACE Inhibitor Angioedema
por: Ejikeme, Chidinma, et al.
Publicado: (2021)

The db/db Mouse: A Useful Model for the Study of Diabetic Retinal Neurodegeneration
por: Bogdanov, Patricia, et al.
Publicado: (2014)

Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i)
por: Pinheiro, Marcelo Maia, et al.
Publicado: (2021)

Retinal microglial activation in glaucoma: evolution over time in a unilateral ocular hypertension model
por: Fernández-Albarral, José A., et al.
Publicado: (2021)

Antiglycative activity of sulforaphane: a new avenue to counteract neurodegeneration?
por: Angeloni, Cristina, et al.
Publicado: (2015)

The socio-economical impact of intravenous (IV) versus subcutaneous (SC) administration of trastuzumab: future prospectives
por: Papadmitriou, K., et al.
Publicado: (2015)

ERp57 in neurodegeneration and regeneration
por: Bargsted, Leslie, et al.
Publicado: (2016)

Oligomers and Neurodegeneration: New Evidence
por: Forloni, Gianluigi
Publicado: (2023)

Active phytochemicals of Pueraria tuberosa for DPP-IV inhibition: in silico and experimental approach
por: Srivastava, Shivani, et al.
Publicado: (2017)

New Insights into the Mechanisms of Action of Topical Administration of GLP-1 in an Experimental Model of Diabetic Retinopathy
por: Sampedro, Joel, et al.
Publicado: (2019)

Immune Checkpoint Inhibitor Therapy for Orbital and Ocular Adnexal Squamous Cell Carcinomas: International Society of Ocular Oncology President's Lecture, 2022
por: Esmaeli, Bita
Publicado: (2023)

Moderate/severe traumatic brain injury as a trigger of chronic neurodegeneration in humans
por: Bagnato, Sergio, et al.
Publicado: (2020)

Topical Ocular Administration of Progesterone Decreases Photoreceptor Cell Death in Retinal Degeneration Slow (rds) Mice
por: Alambiaga-Caravaca, Adrián M., et al.
Publicado: (2022)

DNA damage and neurodegeneration: the unusual suspect
por: Stein, Daniel, et al.
Publicado: (2017)

Olfactory proteotyping: towards the enlightenment of the neurodegeneration
por: Fernández-Irigoyen, Joaquín, et al.
Publicado: (2019)

Downregulation of Signaling-active IGF-1 by Dipeptidyl Peptidase IV (DPP-IV)
por: Lin, Ching-Ting, et al.
Publicado: (2010)

Virtual Screening, Synthesis, and Biological Evaluation of Some Carbohydrazide Derivatives as Potential DPP-IV Inhibitors
por: Jadhav, Prerana B., et al.
Publicado: (2022)

Neuronal Epac1 mediates retinal neurodegeneration in mouse models of ocular hypertension
por: Liu, Wei, et al.
Publicado: (2020)

Neurodegeneration and neuroinflammation: two processes, one target
por: Carriba, Paulina, et al.
Publicado: (2015)

Dendrite pathology and neurodegeneration: focus on mTOR
por: Di Polo, Adriana
Publicado: (2015)

Metabolism, neurodegeneration and epigenetics: emerging role of Sirtuins
por: Silberman, Dafne M.
Publicado: (2018)

Mitochondrial bioenergetics and neurodegeneration: a paso doble
por: Rossi, Alice, et al.
Publicado: (2020)

CD8(+) T cells in neurodegeneration: friend or foe?
por: Hu, Dan, et al.
Publicado: (2022)

Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes
por: Singh, Anand-Krishna, et al.
Publicado: (2021)

In Vivo Evaluation of Retinal Neurodegeneration in Patients with Multiple Sclerosis
por: Tátrai, Erika, et al.
Publicado: (2012)

Nuclear peroxisome proliferator activated receptor-gamma (PPARγ) as a therapeutic target to treat neurodegeneration and dependence elicited by drugs of abuse
por: Ciccocioppo, Roberto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7fndf5db6thmuqh91k2rhi4m0r